About: High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1996 (uk) im Mai 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1996 (ast) scientific article published on 01 May 1996 (en)
publication date	wds:Q71059756-7A3BC6E1-2B92-4410-AD26-A51E0E7570B7
publication date	1996-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71059756-A7366D59-1A82-4457-A7DD-3BB34A9109E0
language of work or name	English
author name string	wds:Q71059756-10D8AB8E-F3F2-43BB-8E70-D37DF63E6518 wds:Q71059756-13A50F6C-BBB1-4CD5-861E-C9384B3A2C42 wds:Q71059756-16D42666-27FF-443A-B736-4299B3E3C9AE wds:Q71059756-5DEC268F-8887-44E7-8B8C-2FBCAEC60056 wds:Q71059756-73B0C0EF-7ABB-4277-85A1-1CA417F81E8E wds:Q71059756-73EE49B1-AB49-433A-BC78-C77BABA94EA4 wds:Q71059756-90800DC1-C476-46B4-AE9A-917CEE34FC3D wds:Q71059756-93CDC5FF-E538-4AEA-AEA9-16E912E880F8 wds:Q71059756-949A3E2E-A016-4891-A018-0DA87C93E3E6 wds:Q71059756-AA58BCAE-C56B-4376-8FC2-D8E5D21C6E41 wds:Q71059756-BB4EF5E0-52B4-4A77-B64B-0E3DFC4B45AF wds:Q71059756-D7A862D0-3292-439C-ACB1-AE4ACFB5B4D5 wds:Q71059756-DC38EB53-0EB8-4807-8BBF-5186A2749A4A wds:Q71059756-DDFB2E59-69DC-4EFC-9037-E003E10DCD25 wds:Q71059756-ECB3E897-04AC-4931-B96C-58D1FEFC91D6
author name string	R T Maziarz L Holmberg T Demirer D G Maloney W I Bensinger T Chauncey S D Rowley T Barnett R A Clift A Fefer K Lilleby C H Weaver P McSweeney K Schiffman J Klarnet
rdfs:label	High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma (en) High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma (nl)
skos:prefLabel	High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma (en) High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma (nl)
name	High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma (en) High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma (nl)
author	wds:Q71059756-28149658-81D4-457B-875E-32DEA1BE1940 wds:Q71059756-39B31862-E551-4674-BA42-BA57DA7C71EB wds:Q71059756-97EA7359-413B-400B-ACB7-89243D384CF9
author	Frederick R. Appelbaum Rainer Storb C. Dean Buckner
title	wds:Q71059756-0BE2D72D-7CD6-4C30-95FC-6967C3B69351
title	High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma (en)
page(s)	wds:Q71059756-B7A22A63-4DC9-4386-B0A1-5C9A8E7DA31B
page(s)	1447-1456
instance of	wds:Q71059756-AF2607B5-9A17-4B3D-BD61-72067610A013
instance of	scholarly article
main subject	wds:Q71059756-517AAD87-DEF0-494D-BDE3-297734CCFB67
main subject	multiple myeloma
PubMed ID	wds:Q71059756-B516AE6A-F3AD-4C9F-8C8F-47F1F562E25D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8622058
PubMed ID	8622058
published in	wds:Q71059756-33CE135A-D697-4582-A921-F4C6648C95FF
published in	Journal of Clinical Oncology
issue	wds:Q71059756-3FCAA82E-1573-4DCB-AA38-6286CED28A83
volume	wds:Q71059756-8FFE500D-4BD3-46EC-893B-8CC4B5EA7835
issue	5
volume	14
DOI	wds:Q71059756-B6613DF6-A217-4645-8BA7-F5E8408DB57B
DOI	http://dx.doi.org/10.1200/JCO.1996.14.5.1447
DOI	10.1200/JCO.1996.14.5.1447
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71059756
is cites work of	Stem-cell transplant preparative regimens Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients. Impact of complete remission with intensive therapy in patients with responsive multiple myeloma Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes Methodologic guidelines for the design of high-dose chemotherapy regimens Standard therapy versus autologous transplantation in multiple myeloma Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Recent Developments and Future Directions in the Treatment of Multiple Myeloma Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study. Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation Efficacy and safety of busulfan-based conditioning regimens for multiple myeloma A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma Autotransplants in multiple myeloma: pushing the envelope Overview of autologous stem cell transplantation. Autologous stem cell transplantation in myeloma: the St James’s Hospital experience, 1997–2003 Sequential, cycling maintenance therapy for post transplant multiple myeloma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 169 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software